GSE146687 irinotecan 2 v 3 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE146687_irinotecan_2_v_3_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE146687_irinotecan_2_v_3_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE146687_irinotecan_2_v_3_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE146687_irinotecan_2_v_3_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

small nucleolar RNA host gene 1

Gene

long intergenic non-protein coding RNA 665

Gene

multidrug resistance-related protein

Gene

H2A clustered histone 4

Gene

STARD4 antisense RNA 1

Gene

ubiquitin specific peptidase 32 pseudogene 1

Gene

ribosomal RNA processing 7 homolog B, pseudogene

Gene

MIR600 host gene

Gene

Zinc finger protein LOC122539214

Gene

MSANTD2 antisense RNA 1

  • Gene

    small nucleolar RNA host gene 1


  • Gene

    long intergenic non-protein coding RNA 665


  • Gene

    multidrug resistance-related protein


  • Gene

    H2A clustered histone 4


  • Gene

    STARD4 antisense RNA 1


  • Gene

    ubiquitin specific peptidase 32 pseudogene 1


  • Gene

    ribosomal RNA processing 7 homolog B, pseudogene



  • Gene

    Zinc finger protein LOC122539214


  • Gene

    MSANTD2 antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.